MultiPlan LP Header
napoli arnall

MultiPlan claims, whether negotiated or priced in any way through Viant, Data iSight may be eligible. 

CONTACT US TODAY >>

MultiPlan, is being sued by thousands of physicians, hospitals, and healthcare providers for violating federal antitrust laws.

MultiPlan and the largest healthcare payers including, United, Cigna, Aetna, Anthem i BlueCross BlueShield entities are accused of fixing the price of out-of-network services in this country.  The case is called In Re: MultiPlan Healthcare Insurance Provider Litigation.

Your healthcare practice may be entitled to collect significant damages and odszkodowanie against Multiplan and these insurance companies. 

NO FEE UNLESS WE WIN YOUR CASE!

Join leading medical associations and thousands of medical providers to pursue your claims.

Zacznij swój Bezpłatny Ocena przypadku

Wypełnij prosty formularz poniżej.

To pole służy do walidacji i powinno pozostać niezmienione.
Are you a member of the American Medical Association (AMA), any state medical society or a specialty medical association?*

Understanding MultiPlan’s Model

MultiPlan leads the profitable business of pricing out-of-network medical claims for such major insurers as United Healthcare, Cigna, Aetna, Anthem and Blue Cross Blue Shield.

Using prorietary algorithms, MultiPlan reviews the medical claim and recommends how much to pay. Access to sensitive pricing data allowed these insurance companies to coordinate and suppress industry-wide reimbursement rates, creating an artificial market depression.

Healthcare specialties impacted by this MultiPlan pricing include:

  • Ambulatory/Outpatient Surgery
  • Addiction Treatment
  • Behavioral Health
  • Emergency Medicine 
  • Hospital Medicine
  • Radiology
  • Anesthesia
  • Chiropractor
  • Orthopedics
MultiPlan Homepage

Aby uzyskać więcej informacji lub skorzystać z bezpłatnej konsultacji bez ryzyka, skontaktuj się z nami już dziś. 

Rozpocznij bezpłatną ocenę sprawy

In the News:

Media Coverage after an Illinois federal judge largely allows antitrust claims to move forward.

  1. US judge rules health insurers, MultiPlan must face price-fixing lawsuits, Reuters
  2. MultiPlan Fails to Escape Reimbursement Collusion Litigation (1), Bloomberg Law
  3. MultiPlan Must Face Reimbursement Pricing Antitrust MDL, Law360
  4. The American Medical Association  applauds court decision allowing lawsuit against MultiPlan to proceed, find their full press release tutaj.

In 2024, after the New York Times published an expose on MultiPlan, the federal government, including the Department of Justice and committees from both the United States Senate and House of Representatives opened investigations in to MultiPlan. Read about them here: 

Serious black woman

Why Hold MultiPlan Accountable?

Unless legal action is taken, providers will continue to be ‘forced’ to use MultiPlan’s algorithms, insurers will continue to minimize their out-of-network payments, and providers will continue to face financial struggle. 

  • Seek Compensation: Recover lost revenue and potentially other damages related to MultiPlan’s’s corporate misconduct.
  • Raise Awareness: Help prevent others from experiencing similar out-of-network pricing issues with MultiPlan.
  • Promote Regulatory Action: The potential for price fixing when MultiPlan’s algorithms are used across multiple insurers has also caught the attention of Congress, prompting investigations. 

Steps to Join the This Lawsuit

If you’re a healthcare provider, professional, or facility whose out-of-network services processed by MultiPlan, you may be entitled to pursue a claim.

1.

Skontaktuj się z nami: Fill out the form above to schedule a free, no-obligation consultation.

2.

Provide Details: Share your experience with MultiPlan and gather any outstanding claims you believe are priced by them. 

3.

Legal Evaluation: Our experienced attorneys will evaluate your case and determine the best course of action.

4.

Pursue Justice: We will guide you through the legal process, fighting tirelessly to secure the compensation you deserve.

Get Started

Często Zadawane Pytania

There are no upfront fees to join the Claritev lawsuit. Our legal team works on contingency. 

We do not charge upfront legal fees and only recover a fee when we win your case. The initial consultation is free. 

We do not anticipate any change in current claims processing based on participation in this lawsuit. There are going to be thousands of providers in this lawsuit across many different specialties.

Yes, all information shared with us is kept completely confidential and protected by numerous levels of technological security. 

Serious black woman

Why Choose Us?

  • Experienced Attorneys: Our team specializes in healthcare litigation, bringing expertise and dedication to your case.
  • No Upfront Fees: We work on a contingency fee basis, meaning you don’t pay unless we win your case.
  • Personalized Attention: We provide individualized attention, understanding the impact MultiPlan’s business model is having on you.

 

MultiPlan Team Hunter Shkolnik, Matt Lavin, Chris Seeger

Hunter J. Szkolnik

Matthew M. Lavin

Christopher R. Seeger

Rozpocznij bezpłatną ocenę sprawy

DEDYKOWANE

TROSKLIWY ZESPÓŁ PRAWNY

WYKWALIFIKOWANY

LEGAL KNOWLEDGE AND
INDUSTRY EXPERTISE

BEZ OPŁATY

CHYBA, ŻE WYGRASZ SWOJĄ SPRAWĘ

Copyright © 2024 | All Rights Reserved | Polityka prywatnościWarunki korzystania. Zasilany przez Stoisko lemoniady.

Napoli Shkolnik jest zarejestrowaną nazwą handlową firmy NSPR Legal Services LLC, Portorykańskiej Spółki z ograniczoną odpowiedzialnością.

Reklama adwokata. Informacje na tej stronie służą wyłącznie celom informacyjnym. Żadna informacja na tej stronie nie powinna być traktowana jako porada prawna w jakimkolwiek indywidualnym przypadku lub sytuacji. Ta informacja nie ma na celu stworzenia, a otrzymanie lub obejrzenie nie stanowi relacji prawnik-klient. Wcześniejsze wyniki wymienione na tej stronie nie gwarantują przyszłych wyników.

Bibliografia: 2021 study:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561257/ 4Nowe badanie ujawnia, że substancje chemiczne zawarte w produktach do pielęgnacji czarnych włosów zwiększają ryzyko raka piersi